INTRODUCTION
SESSION I: BASIC KNOWLEDGE FOR CV DEVICES DEVELOPMENT
Preclinical Evaluation
19 Topics | 5 Quizzes
Biostatistics
33 Topics | 10 Quizzes
SESSION II: TRANSLATIONAL PATHWAY FOR TRANSCATHETER AORTIC VALVE
SESSION III: TRANSLATIONAL PATHWAY FOR TRANSCATHETER MITRAL/TRICUSPID VALVE DEVICES
SESSION IV: TRANSLATIONAL PATHWAY FOR CORONARY STENT
SESSION V: TRANSLATIONAL PATHWAY FOR CATHETER ABLATION
SESSION VI: TRANSLATIONAL PATHWAY FOR VENTRICULAR ASSIST DEVICES
SESSION VII: TRANSLATIONAL PATHWAY FOR INTERVENTIONAL DEVICES FOR HEART FAILURE
SESSION VIII: TRANSLATIONAL PATHWAY FOR LEFT ATRIAL APPENDAGE CLOSURE DEVICES
1 of 2

The TAVR Development from Concept to First in Man

Alain Cribier, MD

Professor of Medicine and Director of Cardiology at the

University of Rouen, Charles Nicolle Hospital, France